Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 14149946

INITIAL EXPERIENCE WITH THROMBOTEST.

A L MILLER·G FARRER-BROWN·J PETHER
View original source ↗Export metadata ↓

Abstract

The initial experience of using Thrombotest instead of Quick's one-stage prothrombin time to control anticoagulant therapy is described.Patients well controlled by the Quick test are often found to be over-anticoagulated by Thrombotest standards, so the introduction of Thrombotest has led to widespread reductions in dosage. No improvement in stability of control has been noted. The main advantages of Thrombotest seem to be its technical simplicity and the comparability of results obtained in different laboratories.

Explore related subjects

AnticoagulantsBlood CoagulationBlood Coagulation TestsHumansPhenindioneProthrombin TimeANTICOAGULANTSBLOOD COAGULATION TESTSPHENINDIONEJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A L MILLER, G FARRER-BROWN, J PETHER. 1964. INITIAL EXPERIENCE WITH THROMBOTEST.. https://doi.org/10.1136/jcp.17.2.182

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

An assessment of the management of patients on warfarin by general dental practitioners in South West Wales.

For anticoagulation therapy, warfarin is used to reduce the risk of thrombo-embolic events in patients with mechanical prosthetic heart valves, certain cardiovascular conditions, deep vein thrombosis (DVT) and hypercoagulable states.(1). The International Normalised Ratio (INR) is used as a measure of anticoagulation and is expressed as a ratio of the patient's prothrombin time (PT) to control prothrombin time. In a person with a normal PT, the INR is approximately 1. The therapeutic range is the value of INR or degree of anticoagulation required to prevent the development of serious thrombo-embolism and is normally maintained between 2.0 and 4.5. It is important to recognize that the INR is only valid for patients on well controlled anticoagulant therapy, ie where the level of anticoagulation is reasonably stable over a moderate length of time.(2).

Anticoagulants↗